Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

1.5K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.5K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

1.7K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.7K
Understanding the Self01:28

Understanding the Self

287
The self is a central aspect of human identity, encompassing an individual’s beliefs, emotions, perceptions, and experiences. It is a cognitive and psychological construct that enables individuals to interpret their traits and behaviors, influencing how they perceive themselves and interact with the world. While personality consists of stable and enduring characteristics, the self is shaped by self-perception and social experiences. This distinction highlights the dynamic nature of the...
287
Fixed Action Patterns01:06

Fixed Action Patterns

17.6K
A fixed action pattern (FAP) is a specific, hard-wired sequence of behaviors that occurs in response to an external stimulus, called a sign stimulus. The behavior is “fixed” because it is essentially unchangeable—proceeding similarly across individuals of a species every time it occurs.
17.6K
Understanding Self-Concept01:20

Understanding Self-Concept

283
The self-concept encompasses individuals' beliefs about themselves, structured through cognitive frameworks known as self-schemas. These schemas function as mental representations of specific traits or behaviors, influencing how self-relevant information is perceived, processed, and remembered. For example, individuals who are schematic for body weight are more likely to interpret routine experiences—such as dining out or shopping—through the lens of that trait. Conversely, those...
283
Understanding Deception01:14

Understanding Deception

168
Deception is a pervasive aspect of human communication. Empirical studies have shown that most individuals engage in some form of deceit on a daily basis, with approximately 20% of social exchanges involving deceptive elements. Lying follows a developmental trajectory, peaking during adolescence and declining with age, possibly due to the maturation of cognitive control and social accountability.Cognitive and Social Factors in Deception DetectionDespite its prevalence, accurately detecting...
168

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is platinum the new gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapies.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

A Cisplatin-Based Prodrug Inhibits Nucleotide Excision Repair Independently of Chromatin Accessibility to Overcome Resistance.

Biomolecules·2026
Same author

Imaging Factors Associated With Poor Outcome in Patients With Basilar Artery Occlusion Treated With Endovascular Thrombectomy.

Stroke (Hoboken, N.J.)·2026
Same author

A New Class of Multitargeting Pt<sup>IV</sup> Anticancer Agents: Prodrugs That Release Pt<sup>II</sup> Drugs and Bioactive Moieties Tethered to Pt<sup>IV</sup> via a Tertiary Amine.

Journal of medicinal chemistry·2026
Same author

Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.

Journal of medicinal chemistry·2025
Same author

A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction.

Angewandte Chemie (International ed. in English)·2025
Same journal

The chemistry of the cobalt corrinoids - Recent advances and emerging themes. Part 3. Cobalamins and health.

Journal of inorganic biochemistry·2026
Same journal

PIKfyve-specific Pt(II)-based targeted drug conjugate in treatment of ovarian cancer through multi-mode actions.

Journal of inorganic biochemistry·2026
Same journal

From PET to targeted radionuclide therapy in the Brain: The emerging role of radiometal-based platforms.

Journal of inorganic biochemistry·2026
Same journal

The chemistry of the cobalt corrinoids - Recent advances and emerging themes. Part 2. The biochemistry, microbiology, and ecology.

Journal of inorganic biochemistry·2026
Same journal

Substituent effects in picolinic acid-derived silver(I) and zinc(II) complexes: Structure, stability, DNA interactions and therapeutic potential.

Journal of inorganic biochemistry·2026
Same journal

Cadmium(II) imidazole coordination complexes as selective antifungal agents against resistant Candida: Insights into protein binding, electrochemistry, and CYP51 binding predictions.

Journal of inorganic biochemistry·2026
See all related articles

Related Experiment Video

Updated: Feb 2, 2026

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

63.3K

Multi-action Pt(IV) anticancer agents; do we understand how they work?

Dan Gibson1

  • 1Institute for Drug Research, School of Pharmacy, The Hebrew University, Jerusalem, 91120, Israel.

Journal of Inorganic Biochemistry
|November 25, 2018
PubMed
Summary
This summary is machine-generated.

Platinum(IV) complexes are prodrugs activated in cancer cells, releasing platinum(II) drugs and bioactive ligands. These multi-action prodrugs can overcome cisplatin resistance by targeting multiple cellular pathways simultaneously.

Keywords:
Anticancer agentsMulti-actionPlatinum(IV)

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.5K

Related Experiment Videos

Last Updated: Feb 2, 2026

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

63.3K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.5K

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Drug Discovery

Background:

  • Platinum(IV) complexes serve as prodrugs, releasing active platinum(II) drugs and ligands within cancer cells.
  • Axial ligands in Pt(IV) complexes can be designed as targeting agents or bioactive moieties to enhance drug properties.
  • Bioactive ligands can transform Pt(IV) prodrugs into multi-action agents targeting multiple cellular pathways.

Purpose of the Study:

  • To explore the potential of multi-action Platinum(IV) prodrugs in cancer therapy.
  • To investigate the mechanism of action for Pt(IV) prodrugs with bioactive ligands.
  • To understand the challenges and potential of overcoming cisplatin resistance using multi-action strategies.

Main Methods:

  • Design and synthesis of Platinum(IV) complexes with bioactive axial ligands.
  • In vitro evaluation of cytotoxicity and cellular target engagement.
  • Analysis of drug resistance mechanisms and multi-target interactions.

Main Results:

  • Platinum(IV) prodrugs demonstrate potent cytotoxicity, often exceeding that of cisplatin.
  • Bioactive ligands can confer multi-action capabilities, leading to simultaneous attacks on several cellular targets.
  • Observed cytotoxicity may not always correlate with the designed enzyme inhibition, suggesting broader cellular effects.

Conclusions:

  • Multi-action Platinum(IV) prodrugs show significant promise for overcoming cisplatin resistance in cancer treatment.
  • The complex interplay of bioactive ligands suggests that "dual-action" prodrugs may exhibit broader multi-action effects.
  • Further research into the design and application of these advanced platinum-based chemotherapeutics is warranted.